Target type: biologicalprocess
The process in which fucose is transported across a lipid bilayer, from one side of a membrane to the other. Fucose is 6-deoxygalactose and has two enantiomers, D-fucose and L-fucose. [GOC:ai]
Fucose transmembrane transport is a crucial process in cellular biology, enabling the movement of the sugar fucose across cell membranes. This movement is essential for various cellular functions, including glycoprotein and glycolipid biosynthesis, cell signaling, and immune responses.
Fucose, a six-carbon sugar, is commonly found in the terminal positions of N-linked glycans on glycoproteins. These glycans play vital roles in cell-cell interactions, protein folding, and immune recognition.
The transport of fucose across cell membranes is mediated by specialized transmembrane proteins known as fucose transporters. These proteins are highly selective for fucose and facilitate its movement against its concentration gradient. This process requires energy, often provided by the hydrolysis of ATP.
Fucose transporters can be classified into two main categories: active transporters and passive transporters. Active transporters utilize energy to move fucose across the membrane against its concentration gradient. Passive transporters, on the other hand, rely on the concentration gradient of fucose to drive its movement.
The specific mechanism by which fucose transporters facilitate transport is still under investigation. However, it is believed that they may utilize a combination of protein conformation changes and binding interactions with fucose molecules to move the sugar across the membrane.
The biological significance of fucose transmembrane transport extends beyond glycoprotein biosynthesis. Fucose plays a role in various cellular processes, including:
- **Cell-cell adhesion:** Fucose residues on glycoproteins contribute to the formation of cell-cell junctions, which are essential for tissue development and organization.
- **Immune recognition:** Fucose-containing glycans on glycoproteins act as ligands for immune cells, influencing immune responses.
- **Signal transduction:** Fucose modification of glycoproteins can alter their interactions with other molecules, influencing signaling pathways.
- **Development and differentiation:** Fucose transport is essential for the proper development and differentiation of various cell types.
Disruptions in fucose transmembrane transport can lead to various pathological conditions, including:
- **Defects in glycoprotein biosynthesis:** Impaired fucose transport can result in the production of aberrant glycoproteins, leading to malfunctions in various cellular processes.
- **Immune dysregulation:** Disruptions in fucose metabolism can affect immune responses, potentially contributing to autoimmune diseases.
- **Developmental abnormalities:** Deficiencies in fucose transport can lead to developmental abnormalities in various tissues and organs.
In conclusion, fucose transmembrane transport is an essential process in cellular biology, playing a critical role in glycoprotein biosynthesis, cell signaling, and immune responses. Understanding the mechanisms and regulation of this transport is crucial for developing therapeutic strategies for various diseases related to fucose metabolism.'
"
Protein | Definition | Taxonomy |
---|---|---|
Sodium/glucose cotransporter 1 | A sodium/glucose cotransporter 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P13866] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
phloretin | dihydrochalcones | antineoplastic agent; plant metabolite | |
phlorhizin | aryl beta-D-glucoside; dihydrochalcones; monosaccharide derivative | antioxidant; plant metabolite | |
vexibinol | sophoraflavanone G : A tetrahydroxyflavanone having a structure of naringenin bearing an additional hydroxyl substituent at position 2' as well as a (2R)-5-methyl-2-(prop-1-en-2-yl)hex-4-en-1-yl (lavandulyl) substituent at position 8'. vexibinol: flavanol from Sophora; structure in first source; RN given refers to (S-(R*,S*))-isomer | (2S)-flavan-4-one; 4'-hydroxyflavanones; tetrahydroxyflavanone | antimalarial; antimicrobial agent; antioxidant; plant metabolite |
2',4',6'-Trihydroxydihydrochalcone | chalcones | ||
2',4',6'-trihydroxychalcone | pinocembrin chalcone : A member of the class of chalcones that is trans-chalcone substituted by hydroxy groups at positions 2', 4' and 6' respectively. pinocembrin chalcone: isolated from Helichrysum trilineatum; structure in first source | chalcones | antifungal agent; plant metabolite |
sergliflozin etabonate | sergliflozin: a hypoglycemic agent that inhibits SGLT2 sodium-glucose transporter; structure in first source | glycoside | |
remogliflozin etabonate | remogliflozin etabonate: orally administered hypoglycemic agent; structure in first source | glycoside | |
dapagliflozin | aromatic ether; C-glycosyl compound; monochlorobenzenes | hypoglycemic agent; sodium-glucose transport protein subtype 2 inhibitor | |
ipragliflozin | glycoside | ||
empagliflozin | aromatic ether; C-glycosyl compound; monochlorobenzenes; tetrahydrofuryl ether | hypoglycemic agent; sodium-glucose transport protein subtype 2 inhibitor | |
1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitol | diarylmethane | ||
nothofagin | nothofagin: a dihydrochalcone | ||
canagliflozin | canagliflozin hydrate : A hydrate that is the hemihydrate form of canagliflozin. Used for treatment of type II diabetes via inhibition of sodium-glucose transport protein subtype 2. | C-glycosyl compound; organofluorine compound; thiophenes | hypoglycemic agent; sodium-glucose transport protein subtype 2 inhibitor |
pf 04971729 | ertugliflozin: structure in first source | diarylmethane | |
deberza | 2-benzofurans |